Urticaria multiforme in a child with SARS-CoV-2 infection
https://doi.org/10.4081/dr.2021.9159
Published: 5 August 2021
Abstract Views: 2190
PDF: 379
HTML: 374
HTML: 374
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
We present a case of a 10-month-old boy with urticaria multiforme in the course of coronavirus disease 2019 (COVID-19). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contributes to skin lesions in both children and adults. The main cutaneous manifestations of this infection include pseudochilblains, urticaria and maculopapular eruptions. Urticaria multiforme is a common yet underrecognized exanthem in children that is precipitated by viral infections among other causes.
Zawadka, K., & Ołdakowska, A. (2021). Urticaria multiforme in a child with SARS-CoV-2 infection. Dermatology Reports, 13(2). https://doi.org/10.4081/dr.2021.9159
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Download data is not yet available.
Citations
